Probable risk factors of internal jugular vein stenosis in Chinese patients-A real-world cohort study

被引:6
|
作者
Bai, Chaobo [1 ,3 ,4 ]
Ding, Jiayue [1 ,3 ,4 ]
Zhou, Da [1 ,3 ,4 ]
Sun, Jingkun [1 ,3 ,4 ]
Liu, Cheng [1 ]
Pan, Liqun [1 ,3 ,4 ]
Ya, Jingyuan [1 ,3 ,4 ]
Wang, Zhongao [1 ,3 ,4 ]
Guan, Jingwei [1 ,3 ,4 ]
Jin, Kexin [1 ,3 ,4 ]
Ding, Yuchuan [4 ,5 ]
Ji, Xunming [2 ,3 ,4 ]
Ding, Jianping [1 ]
Meng, Ran [1 ,3 ,4 ]
机构
[1] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China
[2] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China
[3] Beijing Inst Brain Disorders, Adv Ctr Stroke, Beijing, Peoples R China
[4] Capital Med Univ, Xuanwu Hosp, Dept China Amer Inst Neurosci, Beijing, Peoples R China
[5] Wayne State Univ, Sch Med, Dept Neurosurg, Detroit, MI USA
基金
国家重点研发计划;
关键词
Internal jugular vein stenosis; Contrast-enhanced magnetic resonance venography; Previous hepatitis B virus infection; Osseous; CEREBROSPINAL VENOUS INSUFFICIENCY; INTRACRANIAL HYPERTENSION; CIGARETTE-SMOKING; HEPATITIS-B; THROMBOSIS; DISEASE; HISTORY; ABNORMALITIES;
D O I
10.1016/j.clineuro.2020.105678
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: Extracranial venous anomalies, especially internal jugular vein stenosis (IJVS), have recently received increasing attention, however, its etiologies are uncertain. This study aimed to explore the probable risk factors of IJVS in Chinese Patients and methods: Eligible patients with IJVS confirmed by contrast-enhanced magnetic resonance venography (CE-MRV) were enrolled from October 2017 through October 2018. Probable risk factors were analyzed, including the conditions that may result in IJV wall damage, extraluminal compression, gender and age. Results: A total of 133 patients enrolled in the final analysis, including 73 females and 60 males, the mean age were 54.83 +/- 15.25 years. In this IJVS cohort, the top two risks were previous hepatitis B virus (HBV) infection (48.9 %) and osseous compression (41.4 %). The IJVS cohort was divided into two subsets: extraluminal compression and non-compression. In the former, osseous compression (80.9 %) was the top risk factor, other risks including arterial (22.1 %) and lymph node compression (2.9 %). While, in the latter subset, the most common risk factor was previous HBV infection (46.2 %). In addition, cerebral venous sinus thrombosis (CVST) in non-compression subset was more common than that in extraluminal compression subset (21.5 % VS. 2.9 %, p= 0.001). When considered the gender (Male vs. Female), the ratios were 28.3 % vs. 0 % of smoking, p < 0.001, 16.67 % vs. 1.37 % of hyperhomocysteinemia, p= 0.002, and 11.67 % vs. 1.37 % of hyperuricemia, p= 0.023. In the subset with age less than 45 years, the top three risks included CVST (56.25 %), immunological diseases (55.56 %), and hyperhomocysteinemia (50.00 %), while, in the subset with the ages over 60 years, type2 diabetes (66.66 %), carotid artery compression (53.33 %), previous HBV infection (52.31 %), and osseous compression (49.09 %) were more common than others. Conclusion: This study illustrates the probable risks of IJVS may be diverse, in which osseous compression and previous HBV infection may be the top two probable risks of IJVS in Chinese. This is the biggest difference from previous reports based on Caucasian.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Effects of Traditional Chinese Medicine on the survival of patients with stage Ⅰ gastric cancer and high-risk factors: a real-world retrospective study
    HOU Chao
    ZHANG Yusen
    YANG Die
    LI Yifei
    ZHANG Xiaochun
    LIU Yanqing
    JournalofTraditionalChineseMedicine, 2023, 43 (03) : 568 - 573
  • [22] Using machine learning to identify risk factors for pancreatic cancer: a retrospective cohort study of real-world data
    Su, Na
    Tang, Rui
    Zhang, Yice
    Ni, Jiaqi
    Huang, Yimei
    Liu, Chunqi
    Xiao, Yuzhou
    Zhu, Baoting
    Zhao, Yinglan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [23] Epidemiology and risk factors associated with gout control among adult Asians: a real-world retrospective cohort study
    Oka, Prawira
    Chong, Wei Ming
    Ng, Ding Xuan
    Aau, Wai Keong
    Tan, Ngiap Chuan
    FRONTIERS IN MEDICINE, 2023, 10
  • [24] Baclofen and the Risk of Encephalopathy: A Real-World, Active-Comparator Cohort Study
    Hwang, Y. Joseph
    Chang, Alex R.
    Brotman, Daniel J.
    Inker, Lesley A.
    Grams, Morgan E.
    Shin, Jung-Im
    MAYO CLINIC PROCEEDINGS, 2023, 98 (05) : 676 - 688
  • [25] Baclofen and the risk of fall and fracture in older adults: A real-world cohort study
    Hwang, Y. Joseph
    Chang, Alex R.
    Brotman, Daniel J.
    Inker, Lesley A.
    Grams, Morgan E.
    Shin, Jung-Im
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2024, 72 (01) : 91 - 101
  • [26] Risk Factors for Developing Neovascular Glaucoma in Central Retinal Vein Occlusion: Two-Year Real-World Study
    Chou, Yu-Bai
    Chang, Hsin-Ho
    Chiu, Hsun-, I
    Chou, Yiing-Jenq
    Pu, Christy
    OPHTHALMIC EPIDEMIOLOGY, 2025, 32 (02) : 204 - 212
  • [27] Risk factors for QTc interval prolongation in real-world patients receiving antidepressants
    Okayasu, H.
    Ozeki, Y.
    Fujii, K.
    Okuri, Y.
    Saeki, Y.
    Kunugi, H.
    Shimoda, K.
    Higuchi, T.
    Hori, H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 80 - 80
  • [28] Venous Thromboembolism in Patients With Myeloma: Incidence and Risk Factors in a "Real-World" Population
    Crowley, Maeve P.
    Eustace, Joseph A.
    O'Shea, Susan I.
    Gilligan, Oonagh M.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2014, 20 (06) : 600 - 606
  • [29] Real-world risk factors of confirmed or probable COVID-19 in Americans with diabetes: A prospective, community-based study (iNPHORM)
    Ratzki-Leewing, Alexandria
    Black, Jason E.
    Ryan, Bridget L.
    Harris, Stewart B.
    ENDOCRINOLOGY DIABETES & METABOLISM, 2022, 5 (04)
  • [30] Dupilumab responder types and predicting factors in patients with type 2 severe asthma: A real-world cohort study
    Bult, L.
    Thelen, J. C.
    Rauh, S. P.
    in't Veen, J. C. C. M.
    Braunstahl, G. J.
    RESPIRATORY MEDICINE, 2024, 231